Understanding how gastric bypass surgery affects metabolism and diabetes management

Role of intestinal luminal and epigenetic factors to mediate intestinal metabolic remodeling after gastric bypass surgery

NIH-funded research Boston Children's Hospital · NIH-10597070

This study is looking at how Roux-en-Y gastric bypass surgery helps people with type 2 diabetes by changing the way their intestines work, and it hopes to find new ways to achieve similar benefits without needing surgery.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionBoston Children's Hospital NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-10597070 on NIH RePORTER

What this research studies

This research investigates the mechanisms behind the effectiveness of Roux-en-Y gastric bypass surgery in treating type 2 diabetes. It focuses on how changes in the intestine after surgery can influence energy metabolism and potentially lead to diabetes remission. The study will analyze epigenetic changes in intestinal tissues and how these changes are affected by nutrients in the gut. By using advanced techniques like RNA sequencing and organoid models, the research aims to uncover new therapeutic strategies that could mimic the benefits of surgery without the need for invasive procedures.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with type 2 diabetes who are considering or have undergone gastric bypass surgery.

Not a fit: Patients who do not have type 2 diabetes or those who are not candidates for gastric bypass surgery may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new, less invasive treatments for type 2 diabetes that replicate the metabolic benefits of gastric bypass surgery.

How similar studies have performed: Previous research has shown promising results in understanding metabolic changes after gastric bypass, indicating that this approach has potential for significant advancements.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Non-Insulin-Dependent Diabetes MellitusAdult-Onset Diabetes MellitusKetosis-Resistant Diabetes MellitusMaturity-Onset Diabetes Mellitus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.